MARKET

XOMA

XOMA

Xoma Corp Del
NASDAQ
15.00
+0.16
+1.08%
Closed 16:02 11/28 EST
OPEN
14.68
PREV CLOSE
14.84
HIGH
15.60
LOW
14.68
VOLUME
20.49K
TURNOVER
0
52 WEEK HIGH
23.84
52 WEEK LOW
13.48
MARKET CAP
172.32M
P/E (TTM)
-5.3444
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at XOMA last week (1120-1124)?
Weekly Report · 2d ago
Weekly Report: what happened at XOMA last week (1113-1117)?
Weekly Report · 11/20 11:46
Weekly Report: what happened at XOMA last week (1106-1110)?
Weekly Report · 11/13 11:38
TD Cowen Sticks to Its Hold Rating for Xoma (XOMA)
TipRanks · 11/07 20:46
Solid Revenue Growth and Potential Royalty Increases: A Buy Rating for Xoma
TipRanks · 11/07 16:55
Xoma Corp Del: Quarterly report
Press release · 11/07 13:04
Xoma Corp Del: Current report
Press release · 11/07 13:04
XOMA GAAP EPS of -$0.60 misses by $0.12, revenue of $0.83M misses by $0.36M
Seeking Alpha · 11/07 12:58
More
About XOMA
XOMA Corporation is a biotechnology royalty aggregator. The Company’s drug royalty aggregator business is focused on early to mid-stage clinical assets, primarily in Phase I and II. The Company has a portfolio of economic rights and royalty payments associated with partnered pre-commercial therapeutic candidates. Its royalty portfolio includes AFM13, AFM24, AB002 (proCase/E-WE thrombin), AB023 (xisomab, 3G3), AB054, AZD2936, AV-299 (ficlatuzumab), BAY1213790 (osocimab), CMP-001 (vidutolimod), Lysosomal Storage Disorders Enzymes, COM902, DAY101 (tovorafenib), vosaroxin, INCAGN1876, INCAGN1949, INCAGN02390, INCAGN2385, JNJ-63723283 (cetrelimab), MK-4830, MT-0169, CFZ533 (iscalimab), VPM087 (gevokizumab), NIS793, NIR178, G03-52-01, ebopiprant, PBF-680, PBF-677, PBF-999, PBF-1129, PBF-1650, RZ358, RZ402, faricimab (faricimab-svoa), TAK-079 (mezagitamab), Aldoxorubicin, and Arimoclomol. The Company's subsidiaries include XOMA Technology Ltd., XOMA (US) LLC, and XOMA UK Limited.

Webull offers XOMA Corp stock information, including NASDAQ: XOMA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, XOMA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading XOMA stock methods without spending real money on the virtual paper trading platform.